About Argenta Discovery
Argenta Discovery is a company based in London (United Kingdom) founded in 2000 was acquired by Charles River Laboratories in February 2010. Argenta Discovery operates in a competitive market with competitors including Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Charles River Laboratories
(Feb 08, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Argenta Discovery
Detailed funding history for Argenta Discovery
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Argenta Discovery
Argenta Discovery has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery and preclinical development services
|
Locked | Locked | Locked |
Investor details for Argenta Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Argenta Discovery
Investment portfolio details for Argenta Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Argenta Discovery
Detailed financials for Argenta Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Argenta Discovery Comparisons
Peer comparison for Argenta Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Argenta Discovery
Argenta Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Argenta Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Argenta Discovery
Complete news archive for Argenta Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Argenta Discovery
Argenta Discovery was founded in 2000.
Argenta Discovery is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Christopher Ashton is the current CEO of Argenta Discovery.
Argenta Discovery was founded in 2000 and is headquartered in London, United Kingdom. As a contract research organization (CRO), preclinical testing services for drug development are provided to pharmaceutical and biotechnology clients. Operations encompass various assays and models to evaluate compound efficacy and safety. The company is led by CEO Christopher Ashton, with a focus on supporting early-stage research needs.
Argenta Discovery has 1 investor. Key investors include Charles River Laboratories.